New targeted therapy could bring relief to people with lichen planus
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Medscape7d
Multifaceted Approaches Needed for Inflammatory Vulvar Disease
Teaser: Off-label systemic agents may treat inflammatory autoimmune vulvar diseases such as lichen sclerosus and lichen ...
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...
technologynetworks8d
Targeted Therapy Shows Effectiveness in Skin Disease Patients
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
FDA Approves Expanded Access Program For Lipella Pharma's LP-310 In Oral Lichen Planus; Stock Up
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
Pharmabiz3d
Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus
Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus: Pittsburgh Saturday, February 8, 2025, 09:00 Hr ...
EurekAlert!8d
Skin disease patients show response to targeted treatment
PHOENIX — Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair ...